Ftse Mib
33.746,66
-1,60%
DAX
17.932,17
-1,10%
S&P 500
5.018,39
-0,34%
NASDAQ Composite
15.605,48
-0,33%
Bitcoin
57.720,05
-0,89%

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Theseus Pharmaceuticals Inc (THRX) Theseus Pharmaceuticals Inc (THRX) Notizie

Theseus Pharmaceuticals Inc

THRX
4,06
0,00 (0,00%)
01 Mag 2024 - Chiuso
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
26/2/202415:00EDGAR2Form 15-12G - Securities registration termination [Section..
16/2/202406:15EDGAR2Form EFFECT - Notice of Effectiveness
14/2/202422:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/2/202420:26EDGAR2Form S-8 POS - Securities to be offered to employees in..
14/2/202420:22EDGAR2Form POS AM - Post-Effective amendments for registration..
14/2/202416:44EDGAR2Form 8-K - Current report
14/2/202416:35EDGAR2Form SC TO-T/A - Tender offer statement by Third Party:..
14/2/202414:30PRNUSTheseus Pharmaceuticals Announces Closing of Tender Offer
13/2/202418:36EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
07/2/202423:21EDGAR2Form SC 14D9/A - Solicitation, recommendation statements:..
07/2/202423:15EDGAR2Form SC TO-T/A - Tender offer statement by Third Party:..
30/1/202414:52EDGAR2Form SC 14D9/A - Solicitation, recommendation statements:..
30/1/202414:23EDGAR2Form SC TO-T/A - Tender offer statement by Third Party:..
30/1/202414:00BWConcentra Announces Calculation of Additional Price Per..
10/1/202415:47EDGAR2Form SC 14D9 - Solicitation, recommendation statements
10/1/202414:51EDGAR2Form SC TO-T - Tender offer statement by Third Party
22/12/202312:52EDGAR2Form SC14D9C - Written communication relating to third party..
22/12/202312:36EDGAR2Form 8-K - Current report
22/12/202312:30PRNUSTheseus Pharmaceuticals Enters into Agreement to Be Acquired..
04/12/202312:30EDGAR2Form 8-K - Current report
27/11/202312:37EDGAR2Form 8-K - Current report
27/11/202312:30PRNUSTheseus Pharmaceuticals Confirms Receipt of Unsolicited..
24/11/202322:23EDGAR2Form SC 13D/A - General statement of acquisition of..
17/11/202322:01EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
15/11/202313:00EDGAR2Form NT 10-Q - Notification of inability to timely file Form..
13/11/202322:05PRNUSTheseus Pharmaceuticals Announces Process to Explore..
07/11/202322:05PRNUSTheseus Pharmaceuticals to Participate in the Stifel 2023..
07/11/202322:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
31/10/202321:13EDGAR2Form 8-K - Current report
10/8/202313:06EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
10/8/202313:05EDGAR2Form 8-K - Current report
10/8/202313:00PRNUSTheseus Pharmaceuticals Announces Business Highlights and..
19/7/202320:41EDGAR2Form SC 13D/A - General statement of acquisition of..
14/7/202313:51IHMARKETNEWSFriday’s Wall Street Highlights: JPMorgan Chase, Coinbase,..
13/7/202322:08EDGAR2Form 8-K - Current report
13/7/202322:05PRNUSTheseus Pharmaceuticals to Discontinue Enrollment in Phase..
31/5/202313:00PRNUSTheseus Pharmaceuticals to Participate in the Jefferies..
25/5/202323:01PRNUSTheseus Pharmaceuticals Reports Initial Dose Escalation Data..
11/5/202313:00PRNUSTheseus Pharmaceuticals Announces Business Highlights and..
Apertura: Min: Max:
Chiusura: 4,06

La tua Cronologia

NASDAQ
THRX
Theseus Pharmaceuticals
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' CLICCA QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network